Your session is about to expire
← Back to Search
Fast Track Intervention for Conduct Disorder
N/A
Waitlist Available
Led By Robert J McMahon, PhD
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Must be in 1st grade
Be younger than 18 years old
Must not have
Cannot be older than 1st grade
Timeline
Screening 3 weeks
Treatment Varies
Follow Up grades 10-12 and ages 19, 20, 25, 32, and 34
Awards & highlights
No Placebo-Only Group
Summary
This trial will test whether a comprehensive intervention can prevent severe conduct problems in high-risk children.
Who is the study for?
This trial is for first graders in public schools at 4 study sites, identified as high-risk for severe conduct problems. Children must score in the top 40% on the TOCA-R assessment. Those older than first grade are not eligible.
What is being tested?
The 'Fast Track' program aims to prevent chronic conduct issues among high-risk children. It will be tested if this intervention positively impacts behavior and prevents negative outcomes like delinquency or school dropout.
What are the potential side effects?
Since 'Fast Track' is a behavioral intervention rather than a medication, it may not have typical medical side effects but could include changes in mood or behavior as children adapt to the program.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am currently in the 1st grade.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am in kindergarten or 1st grade.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ grades 10-12 and ages 19, 20, 25, 32, and 34
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~grades 10-12 and ages 19, 20, 25, 32, and 34
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Anti-Social Behaviors
Secondary study objectives
Academic Achievement
Characteristics/Behaviors of Participants' Offspring
Family Formation and Romantic Partnerships
+6 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Fast Track EligibleExperimental Treatment1 Intervention
Participants in the Experimental group received the "Fast Track" intervention. Intervention included school-based curriculum attended by high-risk children, parents, program staff, and occasionally teachers, home visiting, the the in-class PATHS prevention program.
Group II: Control GroupActive Control1 Intervention
Participants in the Control group were not eligible to receive the Fast Track intervention. These children received other services as usual, and served as the randomized comparison group for examining Fast Track program impacts
Find a Location
Who is running the clinical trial?
National Institute of Mental Health (NIMH)NIH
2,918 Previous Clinical Trials
2,739,074 Total Patients Enrolled
17 Trials studying Conduct Disorder
5,524 Patients Enrolled for Conduct Disorder
National Institute on Drug Abuse (NIDA)NIH
2,586 Previous Clinical Trials
3,327,639 Total Patients Enrolled
5 Trials studying Conduct Disorder
1,559 Patients Enrolled for Conduct Disorder
U.S. Department of EducationFED
86 Previous Clinical Trials
53,841 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am in kindergarten or 1st grade.I am currently in the 1st grade.
Research Study Groups:
This trial has the following groups:- Group 1: Fast Track Eligible
- Group 2: Control Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger